background image

Paid Clinical Trials Tulsa

Discover 192 paid clinical trials in Tulsa, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease

Recruiting

Sponsor:

AbbVie

Location:

Tulsa OK, Kansas City MO, Georgetown TX, San Antonio TXshow 15 more

Code:

NCT06107426

Conditions

Parkinson's Disease (PD)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

Recruiting
PHASE3

Sponsor:

Icahn School of Medicine at Mount Sinai

Location:

Tulsa OK, Kansas City MO, Plano TX, Little Rock ARshow 45 more

Code:

NCT04045665

Conditions

Atrial Fibrillation

Stroke

Bleeding

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Antiplatelet-only strategy

Oral Anticoagulant plus background antiplatelet therapy

A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

Recruiting
PHASE3

Sponsor:

Eli Lilly and Company

Location:

Tulsa OK, Bolivar MO, Overland Park KS, Irving TXshow 172 more

Code:

NCT05026866

Conditions

Alzheimer Disease

Eligibility Criteria

Sex: All

Age: 65 - 70+

Healthy Volunteers: Not accepted

Interventions

Donanemab

Placebo

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Recruiting
PHASE3

Sponsor:

Boehringer Ingelheim

Location:

Tulsa OK, Denison TX, Lewisville TX, Garland TXshow 82 more

Code:

NCT06632457

Conditions

Metabolic Dysfunction Associated Steatohepatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Survodutide

Placebo matching survodutide

To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

Recruiting
PHASE3

Sponsor:

Cerevance

Location:

Tulsa OK, Kansas City KS, Memphis TN, Georgetown TXshow 20 more

Code:

NCT06553027

Conditions

Parkinson Disease

Eligibility Criteria

Sex: All

Age: 30+

Healthy Volunteers: Not accepted

Interventions

CVN424 75 mg

CVN424 150 mg

Placebo

A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004

Recruiting
PHASE3

Sponsor:

Intec Pharma Ltd.

Location:

Tulsa OK, Kansas City KS, Bedford TX, Houston TXshow 32 more

Code:

NCT02615873

Conditions

Parkinson's Disease

Eligibility Criteria

Sex: All

Age: 30 - 70+

Healthy Volunteers: Not accepted

Interventions

Accordion Pill™ Carbidopa/Levodopa

Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT

Recruiting
PHASE2

Sponsor:

Mercator MedSystems, Inc.

Location:

Bartlesville OK, Denison TX, Houston TX, Houma LAshow 9 more

Code:

NCT04858776

Conditions

Iliofemoral; Thrombosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Perivascular dexamethasone

Perivascular sham

Efficacy of (WaterWorks®)Douching Device for Elimination of Perceived Vaginal Odor Not Caused by BV or Vaginitis

Recruiting

Sponsor:

Abbott Research Group

Location:

Tulsa OK, Atlanta GA, Detroit MI, Winston Salem NCshow 3 more

Code:

NCT00417365

Conditions

Vaginal Odor

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

WaterWorks Douching Device

Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

Recruiting

Sponsor:

Abbott Medical Devices

Location:

Tulsa OK, Wichita KS, Kansas City MO, Little Rock ARshow 64 more

Code:

NCT03433274

Conditions

Mitral Regurgitation

Mitral Insufficiency

Mitral Valve Insufficiency

Cardiovascular Diseases

Valve Disease, Heart

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tendyne Mitral Valve System

MitraClip System

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Recruiting
PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Tulsa OK, Wichita KS, Osage Beach MO, Tyler TXshow 29 more

Code:

NCT06393374

Conditions

Triple-Negative Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Sacituzumab tirumotecan

Capecitabine